Prosight Management »

Terns Pharmaceuticals shares owned by Prosight Management

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Prosight Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.8M 95k 40.40

More positions owned by Prosight Management

Procept Biorobotics Corp (PRCT)
Galapagos Nv Spon Adr (GLPG)
Janux Therapeutics (JANX)
Adc Therapeutics Sa SHS (ADCT)
Kura Oncology (KURA)
Meiragtx Holdings (MGTX)
Nektar Therapeutics Com New (NKTR)
Veeva Sys Cl A Com (VEEV)
Icon SHS (ICLR)
Boston Scientific Corporation (BSX)
Concentra Group Holdings Par Common Stock (CON)
Phreesia (PHR)
Amicus Therapeutics (FOLD)
Select Medical Holdings Corporation (SEM)
Syndax Pharmaceuticals (SNDX)

View all positions for Prosight Management

Top funds holding Terns Pharmaceuticals

BlackRock
OrbiMed Advisors
Vanguard Group
Vivo Capital
Vestal Point Capital
Adage Capital Partners GP
Holocene Advisors
Franklin Resources
Lord, Abbett & Co
Geode Capital Management
Acorn Capital Advisors
State Street Corporation
Citadel Advisors
Ikarian Capital
Pictet Asset Management Holding SA

View all funds holding Terns Pharmaceuticals